⌘K
Loading ticker…
As of 2026-08-24, Insmed, Inc. (INSM) has a 3-month relative strength percentile of 77 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.8%, relative volume 0.43×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
INSM is held by 54 ETFs as of May 2026. Top owner: QQQM at 0.10% weight, $98M notional. Top 3 carry $215M.
Held by 184 ETFs · $5.4B across latest filings · largest weight 4.59% (BBH).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| QQQMInvesco NASDAQ 100 ETF | 0.10% | $98M | −0.07 pp |
| VHTVanguard Health Care ETF | 0.36% | $68M | −0.11 pp |
| SCHGSchwab U.S. Large-Cap Growth ETF | 0.08% | $49M | −0.04 pp |
| VONGVanguard Russell 1000 Growth ETF | 0.06% | $35M | −0.04 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.03% |
| $24M |
| −0.02 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.03% | $13M | −0.02 pp |
| TQQQProShares UltraPro QQQ | 0.03% | $12M | −0.07 pp |
| QLDProShares Ultra QQQ | 0.06% | $9M | −0.07 pp |
| GSLC | 0.05% | $8M | — |
| ONEQ | 0.05% | $5M | −0.03 pp |
Showing 10 of 54 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | INSM Jan avg: -0.37% median: -1.05% win: 50% σ: 11.29% n: 4 2022-04-12 → 2026-07-31 | INSM Feb avg: -0.99% median: -2.55% win: 25% σ: 5.47% n: 4 2022-04-12 → 2026-07-31 | INSM Mar avg: -3.85% median: -4.29% win: 25% σ: 10.71% n: 4 2022-04-12 → 2026-07-31 | INSM Apr avg: -5.01% median: -8.27% win: 20% σ: 11.58% n: 5 2022-04-12 → 2026-07-31 | INSM May avg: 16.24% median: -3.15% win: 20% σ: 60.05% n: 5 2022-04-12 → 2026-07-31 | INSM Jun avg: 16.29% median: 10.88% win: 80% σ: 17.69% n: 5 2022-04-12 → 2026-07-31 | INSM Jul avg: 4.90% median: 6.60% win: 80% σ: 7.48% n: 5 2022-04-12 → 2026-07-31 | INSM Aug avg: 10.59% median: 8.21% win: 75% σ: 11.94% n: 4 2022-04-12 → 2026-07-31 (current) | INSM Sep avg: 1.03% median: 0.64% win: 50% σ: 12.14% n: 4 2022-04-12 → 2026-07-31 | INSM Oct avg: 0.87% median: -4.29% win: 25% σ: 21.95% n: 4 2022-04-12 → 2026-07-31 | INSM Nov avg: 6.97% median: 8.17% win: 75% σ: 5.17% n: 4 2022-04-12 → 2026-07-31 | INSM Dec avg: 1.89% median: -0.04% win: 50% σ: 17.79% n: 4 2022-04-12 → 2026-07-31 |